MCM
BLUE

Mazama Capital Management’s bluebird bio BLUE Stock Holding History

Mazama Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-405
Closed -$634K – 287
2015
Q1 		$634K Buy
405
+378
+1,400% +$499K 0.13% 172
2014
Q4 		$33K Sell
27
-1,133
-98% -$757K 0.01% 245
2014
Q3 		$539K Buy
1,160
+348
+43% +$161K 0.14% 170
2014
Q2 		$405K Buy
812
+670
+472% +$215K 0.11% 190
2014
Q1 		$42K Sell
142
-352
-71% -$107K 0.04% 162
2013
Q4 		$134K Sell
494
-2,839
-85% -$793K 0.07% 138
2013
Q3 		$1.16M Buy
3,333
+1,017
+44% +$378K 0.64% 61
2013
Q2 		$749K Buy
+2,316
New +$764K 0.47% 80

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Mazama Capital Management's BLUE Position: Q2 2015 in Review

Mazama Capital Management sold out of bluebird bio (BLUE) in Q2 2015, closing a stake of 405 shares — an estimated $634K sold.

Mazama Capital Management first reported a position in BLUE in Q2 2013 and held it in 8 quarters. The position peaked at $1.16M in Q3 2013. 235 funds tracked by Wall St. Rank hold BLUE as of Q2 2015.

  • Mazama Capital Management reported no remaining bluebird bio position as of Q2 2015 after selling out during the quarter.
  • Mazama Capital Management sold 405 bluebird bio shares in Q2 2015, an estimated $634K.
  • Mazama Capital Management first reported a position in bluebird bio in Q2 2013 and held it in 8 quarters.
  • Mazama Capital Management's bluebird bio position peaked at $1.16M in Q3 2013.
  • 235 funds tracked by Wall St. Rank held bluebird bio as of Q2 2015.

Based on Mazama Capital Management's 13F filing for Q2 2015, filed 24 Aug 2015.